名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
Reviva Pharmaceuticals Holdings Inc | RVPH | NASDAQ | 普通株式 |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
2.96 | 2.80 | 3.0515 | 2.80 | 2.94 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/2/17 | 06:32 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
2024/2/14 | 14:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
2024/2/14 | 07:00 | EDGAR2 | Form 424B4 - Prospectus [Rule 424(b)(4)] |
2024/2/03 | 06:38 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
2023/11/18 | 06:05 | EDGAR2 | Form 8-K - Current report |
2023/11/18 | 06:03 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
2023/11/15 | 06:12 | EDGAR2 | Form 8-K - Current report |
2023/10/30 | 21:20 | EDGAR2 | Form 8-K - Current report |
2023/10/05 | 06:03 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
2023/10/05 | 06:02 | EDGAR2 | Form 8-K - Current report |
2023/8/17 | 19:30 | EDGAR2 | Form 8-K - Current report |
2023/8/15 | 05:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2023/8/15 | 05:15 | EDGAR2 | Form 8-K - Current report |
2023/7/25 | 05:16 | EDGAR2 | Form 8-K - Current report |